SCHEMBL5582333

SCHEMBL5582333

CCOC(=O)C(C)=Cc1cc(-c2cccc(Cl)c2)c2cnc(NC)nc2c1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.40
CSNK2A2 P19784 2/20 0.38
CSNK2B P67870 2/20 0.38
CSNK2A1 P68400 2/20 0.38
MAPT P10636 3/20 0.36
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
POLQ O75417 1/20 0.35
DYRK3 O43781 1/20 0.35
DYRK1A Q13627 1/20 0.35
DYRK2 Q92630 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.35
XPO1 O14980 1/20 0.35
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
KMT2A Q03164 1/20 0.34
GAA P10253 1/20 0.34
PTGS2 P35354 1/20 0.34
MAP4K4 O95819 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5582331 1.00 ADORA1 (0.40) ADORA1CSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL5582181 0.90 ADORA1 (0.42) ADORA1CSNK2A2CSNK2BCSNK2A1POLQ
SCHEMBL5582182 0.90 ADORA1 (0.42) ADORA1CSNK2A2CSNK2BCSNK2A1POLQ
SCHEMBL5582080 0.86 CCNC (0.41) ADORA1CSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL5582074 0.86 CCNC (0.41) ADORA1CSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL5582233 0.83 ADORA1 (0.40) ADORA1CSNK2A2CSNK2BCSNK2A1JAK2
SCHEMBL5581783 0.82 ADORA1 (0.42) ADORA1CSNK2A2CSNK2BCSNK2A1POLQ
SCHEMBL5581781 0.82 ADORA1 (0.42) ADORA1CSNK2A2CSNK2BCSNK2A1POLQ
SCHEMBL5581542 0.81 MAPT (0.41) ADORA1CSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL5582125 0.81 ADORA1 (0.38) ADORA1CSNK2A2CSNK2BCSNK2A1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225308-A1 2-Amino Quinazoline Derivative KYOWA HAKKO KOGYO CO.,LTD. (JP) 2007-09-27 US disclosed
EP-1726584-A1 2-AMINOQUINAZOLINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225308-A1 2-Amino Quinazoline Derivative AGTR2, ABL1, AGTR1 ADORA1 406/4885CSNK2A2 467/4885CSNK2B 662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.